<i>CSMD1</i> Mutations Are Associated with Increased Mutational Burden, Favorable Prognosis, and Anti-Tumor Immunity in Gastric Cancer

Tumor mutational burden (TMB) is considered a potential biomarker for predicting the response and effect of immune checkpoint inhibitors (ICIs). To find specific gene mutations related to TMB and the prognosis of patients, the frequently mutated genes in gastric cancer patients from TCGA and ICGC we...

Full description

Bibliographic Details
Main Authors: Taobi Huang, Yuan Liang, Huiyun Zhang, Xia Chen, Hui Wei, Weiming Sun, Yuping Wang
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Genes
Subjects:
Online Access:https://www.mdpi.com/2073-4425/12/11/1715